In addition to obesity and diabetes, the condition GLP-1 drugs like semaglutide were initially tapped to treat, Wegovy now includes cardiovascular benefits on its label
November 14th, 2025: Three New Jersey Cases Added to Expanding GLP-1 Drug MDL A federal judicial panel has transferred three additional lawsuits from New Jersey into the growing multidistrict litigation involving claims that Eli Lilly and Novo Nordisk minimized the safety risks associated with GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Trulicity
(b) TIR efficacy in neuroprotection
These standards guarantee research grade consistency and reliability across all product batches for reproducible results in various research settings
Surprisingly, no associations were found between GLP-1 receptor agonists and breast cancer risk. People prescribed GLP-1s had a higher risk for kidney cancer compared with those receiving metformin (HR = 1.54
Constipation becomes the dominant side effect for many patients after nausea subsides